Объективные ограничения по увеличению количества доноров для трансплантации сердца
https://doi.org/10.15825/1995-1191-2018-4-142-145
Аннотация
Трансплантация сердца признана методом выбора лечения терминальной сердечной недостаточности. В последние годы число таких операций остается неизменным во всем мире. Несмотря на снижение смертности в листе ожидания, благодаря применению различных методов вспомогательного кровообращения остается актуальным максимальное использование всего донорского потенциала. Реципиенты донорского сердца имеют все больше сопутствующей патологии. Сохраняющаяся диспропорция между увеличением числа кандидатов на трансплантацию сердца и количеством доступных органов требует максимального использования торакальных органов для трансплантации.
Об авторах
А. Цукерманн
Медицинский университет Вены
Австрия
Австрия
Währinger Gürtel 18-20, 1090 Vienna
Tel. +431404005643
Г. Лауфер
Медицинский университет Вены
Австрия
Австрия
Список литературы
1. D’Allesandro C, Golmard JL, Barreda E, Laali M, Makris CE, Leprince P et al.Predictive risk factors for primary graft failure requiring temporary extracorporeal membrane oxygenation support after cardiac transplantation in adults. Eur J Cardiothorac Surg. 2011; 40: 962–969.
2. Lund LH, Edwards LB, Kucheryavaya AY et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-first Official Adult Heart Transplant Report-2014; focus theme: retransplantation. J Heart Lung Transplant. 2014; 33: 996–1008.
3. Organ Procurement and Transplantation Network. https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/# Accessed 6 August 2017.
4. ColvinAdams M, Smithy JM, Heubner BM et al. OPTN/SRTR 2012 Annual Data Report: heart. Am J Transplant. 2014; 14 (Suppl 1): 113–138.
5. Mehra MR, Canter CE, Hannan MM et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update. J Heart Lung Transplant. 2016; 35: 1–23.
6. Khush K, Cherikh WS, Chambers DC et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-fifth adult heart transplantation report – 2018; focus theme: multiorgan transplant. J Heart Lung Transplant. 2018; 37: 1155–1168.
7. Laks H. Only optimal donors should be accepted for heart transplantation: antagonist. J Heart Lung Transplant. 1995; 14: 1043–1046.
8. Roig E, Almenar L, CrespoLeiro M et al. Heart transplantation using allografts from older donors: multicenter study results. J Heart Lung Transplant. 2015; 34: 790–796.
9. Stehlik J, Edwards LB, Kucheryavaya AY, Aurora P, Christie JD, Kirk R, Dobbels F, Rahmel AO, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report – 2010. J Heart Lung Transplant. 2010; 29: 1089–1103.
10. Chen CW, Sprys MH, Gaffey AC et al. Low ejection fraction in donor hearts is not directly associated with increased recipient mortality. J Heart Lung Transplant. 2017; 36: 611–615.
11. Madan S, Saeed O, Vlismas P et al. Outcomes after transplantation of donor hearts with improving left ventricular systolic dysfunction. J Am Coll Cardiol. 2017; 70: 1248–1245.
12. Mehra MR, Jarcho JA, Cherikh W et al. The drug-intoxication epidemic and solid-organ transplantation. N Engl J Med. 2018; 378: 1943–1945.
13. Jayarajan S, Taghavi S, Komaroff E et al. Long-term outcomes in heart transplantation using donors with a history of past and present cocaine use. Eur J Cardiothorac Surg. 2015; 47: 146–150.
14. Schlendorf KH, Zalawadiya S, Shah AS et al. Early outcomes using hepatitis C-positive donors for cardiac transplantation in the era of effective direct-acting anti-viral therapies. J Heart Lung Transplant. 2018; 37: 763–769.
15. Tenderich G, Koerner MM, Stuettgen B et al. Extended donor criteria: hemodynamic follow-up of heart transplant recipients receiving a cardiac allograft from donors > or = 60 years of age. Transplantation. 1998; 66: 1109–1113.
16. Forni A, Luciani GB, Chiominto B, Pizzuti M, Mazzucco A, Faggian G. Results with expanded donor acceptance criteria in heart transplantation. Transplant Proc. 2011; 43: 953–959.
17. Wittwer R, Wahlers T. Marginal donor grafts in heart transplantation: lessons learned from 25 years of experience. Transplant Int. 2008; 21: 113–125.
18. Messer SJ, Axell RG, Colah S et al. Functional assessment and transplantation of the donor heart after circulatory death. J Heart Lung Transplant. 2016; 35: 1443– 1452.
19. Mehra MR. Challenges, diligence, and a breakthrough in donation after circulatory death in heart transplantation. J Heart Lung Transplant. 2017; 36: 1319–1321.
20. Keller CA, Gonwa TA, White LJ et al. Utilization and cost analysis of lung transplantation and survival after 10 years of adopting the lung allocation score (LAS) [e-pub ahead of print]. Transplantation 2018. https://doi.org/10.1097/TP.0000000000002227, accessed September 6, 2018.
21. Davies RR, Farr M, Silvestry S et al. The new United States heart allocation policy: progress through collaborative revision. J Heart Lung Transplant. 2017; 36: 595–596.
22. Smits JM, de Vries E, De Pauw M et al. Is it time for a cardiac allocation score? First results from the Eurotransplant pilot study on a survival benefit-based heart allocation. J Heart Lung Transplant. 2013; 32: 873–880.
23. Trivedi JR, Cheng A, Ising M, Lenneman A, Birks E, Slaughter MS. Heart transplant survival based on recipient and donor risk scoring: A UNOS database analysis. ASAIO J. 2016; 62: 297–301.
Рецензия
Для цитирования:
Цукерманн А., Лауфер Г. Объективные ограничения по увеличению количества доноров для трансплантации сердца. Вестник трансплантологии и искусственных органов. 2018;20(4):142-145. https://doi.org/10.15825/1995-1191-2018-4-142-145
For citation:
Zuckermann A., Laufer G. Rationale limits of organ donor maximization for heart transplantation. Russian Journal of Transplantology and Artificial Organs. 2018;20(4):142-145. https://doi.org/10.15825/1995-1191-2018-4-142-145
Просмотров: 723
Послать статью по эл. почте 